USPTO serial 90647417
CELIACARE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 23, 2024
- Examiner
- RITTNER, HANNO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CELIACARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boca Raton, FL
Boca Raton, FL
BOCA RATON, FL
BOCA RATON, FL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephen P. McNamara
Stephen P. McNamara ST. ONGE STEWARD JOHNSTON & REENS LLC986 BEDFORD STREETSTAMFORD, CT 06905UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Immunochromatographic test cartridges for clinical testing the presence of antibodies to gluten; medical devices, namely, immunochromatographic test cartridges, for clinical testing for anti-tissue transglutaminase IgA antibodies; celiac disease diagnosis and screening testing kits comprised of disinfectant alcohol wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, blood collection micropipette to obtain blood sample from lancet site, container of dilution buffer to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood sample; gluten sensitivity and intolerance testing kits comprised of disinfectant wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, micropipette to obtain blood sample from lancet site, container of diluent to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood | ACTIVE | Nov 13, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by New Day Diagnostics LLC
- Other trademarks owned by New Day Diagnostics LLC
- Other trademarks owned by NEW DAY DIAGNOSTICS LLC
- Other trademarks owned by NEW DAY DIAGNOSTICS LLC
- Other trademarks in Class 005
- Similar marks named CELIACARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 20, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 17, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 17, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 23, 2024 | IUAF | USE AMENDMENT FILED | — |
| Feb 23, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 23, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 23, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 23, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 11, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 22, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 18, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 18, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 18, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 10, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 6, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 6, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 23, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 28, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 28, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 20, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 17, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 19, 2021 | NWAP | NEW APPLICATION ENTERED | — |